Results 141 to 150 of about 71,650 (224)

Caracterização funcional da proteína LRR17 em Leishmania (Leishmania) major. [PDF]

, 2015
openaire   +1 more source

The Unusual Invader in a Patient with Long-Standing Rheumatoid Arthritis: A Case of <i>Leishmania major</i> Colonization of Rheumatoid Nodules. [PDF]

Dermatopathology (Basel)
Di Prete M, Lora V, Lamberti A, Latini A, Cota C.   +4 more
europepmc   +1 more source

The Role of BRCT Domain from LmjPES in <i>Leishmania major</i> Pathogenesis. [PDF]

Biomolecules
Larrea E, Peña-Guerrero J, Fernández-Rubio C, Burguete-Mikeo A, Guruceaga E, Nguewa P.   +5 more
europepmc   +1 more source

Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by <i>Leishmania major</i>. [PDF]

Pharmaceutics
El-Dirany R, Ginatta P, Fernández-Rubio C, Burguete-Mikeo A, Larrea E, Martinez-de-Tejada G, Nguewa PA.   +6 more
europepmc   +1 more source

Silver-<i>N</i>-Heterocyclic Complexes Against <i>Leishmania major</i>: In Vitro, In Vivo and In Silico Therapeutic Activities. [PDF]

Pharmaceuticals (Basel)
Şahin N, Polat ZA, Gülpınar DG, Ataş AD, Üstün E, Özdemir İ, Sémeril D.   +6 more
europepmc   +1 more source

Persistent antigen is essential for sustaining <i>Leishmania major</i>-specific memory CD4⁺ T cells and long-term immunity. [PDF]

Sci Adv
Mou Z, Zayats R, Salako E, Ikeogu N, Onwah SS, Liu D, Hamana H, Kishi H, Tan D, Leung C, Arsenio J, Murooka TT, Uzonna JE.   +12 more
europepmc   +1 more source

Impact of Asaia bacteria on Leishmania major development in sand flies: implications for vector control strategies. [PDF]

Parasit Vectors
Stejskalova M, Jancarova M, Pruzinova K, Capova K, Varotto-Boccazzi I, Epis S, Volf P.   +6 more
europepmc   +1 more source

Metabolic systems biology of Leishmania major

, 2019
Protozoan parasitic diseases such as leishmaniasis, toxoplasmosis, and sleeping sickness are one of the major causes of death worldwide. The emerging resistance of parasitic species and adaptive mechanisms of infection are a major concern in developing medical treatment.
openaire   +1 more source

<i>In vitro</i> activity of gallium-protoporphyrin IX against <i>Leishmania major</i> and <i>Leishmania infantum</i>. [PDF]

Microbiol Spectr
Maestrini S, Diotallevi A, Hijazi S, Habouria S, Frangipani E, Galluzzi L.   +5 more
europepmc   +1 more source

Nanofibrous patches for targeted therapy of cutaneous leishmaniasis caused by Leishmania major: a preclinical amphotericin B platform. [PDF]

Parasitol Res
Allahmoradi M, Mohebali M, Mirjalali H, Adabi M, Karder FF, Rezayat SM, Foroushani AR, Mousavi SE, Kazemirad E.   +8 more
europepmc   +1 more source